BRIEF-Iq3corp Says Oncotex Inc Signed A Manufacturing Agreement With Sterling Pharma Solutions
- ByReuters-
April 29 (Reuters) - Iq3corp Ltd IQ3.AX :* ONCOTEX INC SIGNED A MANUFACTURING AGREEMENT WITH STERLING PHARMA SOLUTIONS
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
iQ3Corp Ltd (IQ3)
Sydney
Symbol | Exchange | Currency |
|---|
0.120
0.000(0.00%)
- Volume:0
- Bid/Ask:0.091/0.120
- Day's Range:0.120 - 0.120
IQ3 Overview
- Prev. Close
- 0.125
- Day's Range
- 0.12-0.12
- Revenue
- 650K
- Open
- 0.12
- 52 wk Range
- 0.072-0.17
- EPS
- -0.05
- Volume
- 0
- Market Cap
- 12.52M
- Dividend (Yield)
- N/A(N/A)
- Average Volume (3m)
- 5,830
- P/E Ratio
- -
- Beta
- -
- 1-Year Change
- -22.58%
- Shares Outstanding
- 104,341,001
- Next Earnings Date
- -
What is your sentiment on iQ3Corp Ltd?
or
Market is currently closed. Voting is open during market hours.
iQ3Corp Ltd News
- BRIEF-Iq3corp Acquires Interest In A New Anticancer Drug Platform From University Of Texas
- ByReuters-
Sept 17 (Reuters) - Iq3corp Ltd IQ3.AX :* ONCOLOGY FRANCHISE - ONCOTEX INC. - HAS ACQUIRED A NOVEL ANTICANCER DRUG PLATFORM
- BRIEF-Iq3corp responds to ASX query
- ByReuters-
Feb 1 (Reuters) - Iq3corp Ltd IQ3.AX * Responds to ASX query * "Does not expect to have a continued negative operating cash flow" * Company does not believe raising of further...
iQ3Corp Ltd Company Profile
iQ3Corp Ltd Company Profile
iQ3Corp Ltd is an Australia-based company that is engaged in the provision of capital raising and corporate advisory services to listed and unlisted companies in the life science industry. The Company's segments include consulting services and shared services. consulting services segment includes capital raising and corporate advisory fees. shared services segment includes office and shared services revenue. It provides advices to life science companies on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and corporate finance to corporations, partnerships, institutions, governments, and individuals. It offers various services, such as initial public offerings, listings, private equity, merger and acquisitions, sell-side advisory, buy-side advisory, structured finance and N.S.X. nominated advisor. The Company has six wholly owned subsidiaries.
Read More
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | |||||
| Technical Indicators | |||||
| Summary |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 7.18 | 7.21 | 7.10 | +0.060 | +0.84% | 8.94M | Sydney | |||
| 38.83 | 39.19 | 38.76 | -0.320 | -0.82% | 6.09M | Sydney | |||
| 18.94 | 19.25 | 18.81 | -0.140 | -0.73% | 4.77M | Sydney | |||
| 100.34 | 100.35 | 99.46 | -0.510 | -0.51% | 2.63M | Sydney | |||
| 0.086 | 0.087 | 0.082 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 0.14 | 0.14 | 0.14 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 0.004 | 0.004 | 0.004 | 0.000 | 0.00% | 4.00M | Sydney | |||
| 1.47 | 1.495 | 1.46 | -0.030 | -2.00% | 3.39M | Sydney | |||
| 0.002 | 0.002 | 0.002 | 0.000 | 0.00% | 180.97K | Sydney | |||
| 0.36 | 0.365 | 0.36 | +0.020 | +5.88% | 777.00 | Sydney | |||
| 0.044 | 0.044 | 0.044 | 0.000 | 0.00% | 0.00 | Sydney | |||
| 0.047 | 0.047 | 0.046 | 0.000 | 0.00% | 498.21K | Sydney | |||
| 0.032 | 0.033 | 0.032 | -0.001 | -3.03% | 329.58K | Sydney | |||
| 45.55 | 45.88 | 45.17 | -0.49 | -1.06% | 489.80K | Sydney | |||
| 33.55 | 33.88 | 32.59 | -1.070 | -3.09% | 1.28M | Sydney |